Atherosclerosis
Atherosclerosis is a cardiovascular condition studied in relation to blood lipids, fatty streaks in the aorta, tissue perfusion, and microcirculation. Research on options such as Garlic, Omega-3, Acetyl-L-Carnitine (ALCAR), and Astragalus does not represent one uniform type of evidence, so findings should be interpreted in context.
Atherosclerosis is a cardiovascular condition with important terminology to understand at a glance.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
2 options:1 not enough evidence1 not tested in people
High-Intensity Interval Training (HIIT)practiceNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A review found that HIIT reduced carotid intima-media thickness compared with no exercise in patients with carotid atherosclerosis.
Open the High-Intensity Interval Training (HIIT) pageCardiopracticeNot tested in people
Only tested in animals, cells or theory. Results like these often do not carry over to people.
The one study found a benefit.
In ApoE-/- mice, 16 weeks of voluntary aerobic exercise reduced aortic lesion area, improved endothelium-dependent relaxation, increased eNOS, and reduced vascular inflammation compared with sedentary controls.
Open the Cardio page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition2 listedThe best we have, but the evidence is still weak
- →PracticesHigh-Intensity Interval Training (HIIT)CertaintyLowSourceRCT
A review found that HIIT reduced carotid intima-media thickness compared with no exercise in patients with carotid atherosclerosis.
Who was studied
- Healthy people and patients
- Heart Disease
- Metabolic Syndrome
Open High-Intensity Interval Training (HIIT)Study result
HIIT significantly reduced CIMT compared with no exercise in carotid atherosclerosis patients.
- →PracticesCardioCertaintyLowSourceAnimal research
In ApoE-/- mice, 16 weeks of voluntary aerobic exercise reduced aortic lesion area, improved endothelium-dependent relaxation, increased eNOS, and reduced vascular inflammation compared with sedentary controls.
Who was studied
- People with a condition
Open CardioStudy result
In ApoE-/- mice, 16 weeks of voluntary aerobic exercise reduced aortic lesion area, improved endothelium-dependent relaxation, increased eNOS, and reduced vascular inflammation versus sedentary controls.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Atherosclerosis worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Atherosclerosis is a cardiovascular condition studied in relation to blood lipids, fatty streaks in the aorta, tissue perfusion, and microcirculation. Research on options such as Garlic, Omega-3, Acetyl-L-Carnitine (ALCAR), and Astragalus does not represent one uniform type of evidence, so findings should be interpreted in context. Atherosclerosis is a medical condition; discuss its management with a clinician.
Evidence-backed options
The evidence spans several different types of findings rather than one consistent treatment approach. Garlic has been studied as an AGE supplement for 12 months in people with arteriolosclerosis and coronary artery disease, with findings related to peripheral tissue perfusion and microcirculation. By contrast, the omega-3 evidence examined approximately 1 g/d in people with a history of CHD and provided no support for preventing fatal CHD, nonfatal MI, or other vascular events.
Several options are supported mainly by experimental or review-level findings. Across these, the proposed areas of interest include blood lipids, vascular inflammation, oxidative stress, aortic fatty streaks, and arterial calcification. Acetyl-L-Carnitine (ALCAR), Curcumin, Astragalus, and Lycopene include findings from animal or preclinical models, while Berberine, L-Carnitine, Lutein, Magnesium, Melatonin, and Reishi are described through reviews or observational or clinical findings. These results do not establish that the same effects occur in people with Atherosclerosis.
The available findings do not provide a consistent dose, treatment duration, or time to onset for most options. Apart from the 12-month Garlic study and the approximately 1 g/d omega-3 context, the timing and amount used are not specified here. Evidence is therefore especially thin for options supported by theoretical rationale or animal research, and the clinical findings should not be read as proof of improved cardiovascular outcomes. Anyone considering supplements in relation to Atherosclerosis should discuss the evidence and individual circumstances with a clinician.